Global Global Cell Viability Assays Market Size, Share, Analysis, Trends, Growth, 2032

Cell Viability Assays Industry Perspective

What will be the global cell viability assays market size during the forecast period?

The global cell viability assays market size was worth around USD 14.21 billion in 2023 and is predicted to grow to around USD 31.61 billion by 2032, with a compound annual growth rate (CAGR) of roughly 9.29% between 2024 and 2032.

This report provides a comprehensive analysis of the growth drivers, restraints, and challenges shaping demand across the global cell viability assays market throughout the forecast period, while highlighting high-potential emerging opportunities within the industry.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global cell viability assays market is estimated to grow at a CAGR of approximately 9.29% during the forecast period from 2024 to 2032.
• In terms of revenue, the global cell viability assays market size was valued at around USD 14.21 billion in 2023 and is projected to reach USD 31.61 billion by 2032.
• The market is driven by the rising prevalence of chronic and infectious diseases, increasing investments in drug development and cell-based research, and continuous advancements in assay technologies including automation and high-content imaging.
• Based on the product, the consumables segment is anticipated to dominate the market due to the growing demand for assay kits and reagents in cell-related research activities and the recurring nature of these purchases.
• Based on the application, the drug discovery and development segment held the largest share owing to the increasing prevalence of infectious and chronic diseases that require efficient screening and toxicity testing.
• Based on the end-user, the pharmaceutical and biotechnology companies segment dominated the market due to the rising number of such organizations and the intensive research activities they conduct.
• Regionally, North America is predicted to lead the global market owing to the high prevalence of infectious diseases, extensive research activities, and the presence of well-developed research and clinical laboratories.

Cell Viability Assays Market: Overview

For the purpose of determining the general health and function of cells, as well as the quantity of viable cells present in a sample, cell viability assays are experimental techniques that are utilized. Research in the fields of cell biology, pharmacology, toxicology, and drug development frequently makes use of these assays in order to evaluate the impact of a variety of substances, therapies, or situations on the survival of cells.

Assessment of cell viability can be accomplished by a variety of approaches, each of which has its own set of benefits and drawbacks. Among the most popular forms of cell viability tests are the following:

Assay for the Exclusion of Trypan Blue:  This test includes staining non-viable cells with Trypan Blue dye, which has the ability to penetrate cells that have membranes that have been damaged. However, non-viable cells are able to absorb the dye, which results in a blue coloration. Viable cells are able to avoid the dye. A microscope can then be used to count the cells that have not been labeled, which will allow for the determination of the number of live cells.

The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay is performed as follows:  The activity of the cells' metabolic processes is measured by this assay. In metabolically active cells, mitochondrial enzymes are responsible for the transformation of MTT, which is a yellow tetrazolium salt, into formazan crystals, which are purple in color. The formazan crystals are solubilized after a predetermined amount of time has passed during the incubation process, and the absorbance is then measured using spectrophotometry. A direct proportional relationship exists between the quantity of live cells and the intensity of the color that is generated.

Resazurin Assay:  During the resazurin assay, metabolically active cells convert the non-toxic blue dye resazurin into the highly fluorescent resorufin. Resazurin is a cell-permeable dye. Quantification of the reduction of resazurin can be accomplished through the measurement of fluorescence or absorbance, with the signal intensity developing a correlation with the number of live cells.

LDH Assay (Lactate Dehydrogenase):  LDH is a cytoplasmic enzyme that is released into the supernatant of the cell culture when the cell membrane is damaged. This release indicates that the cell has died or that it has been cytotoxic. This test determines the level of LDH activity in the supernatant, which serves as an indicator of the integrity of the cell membrane and the level of cytotoxicity.

Assessment of Adenosine Triphosphate (ATP):  Adenosine triphosphate (ATP) is a substance that is found in every living cell and acts as a marker of the metabolic activity and survival of biological cells. It is possible to determine whether or not ATP is present through the use of luminescence-based technologies, with the signal intensity being proportional to the number of live cells.

These assays have the potential to offer researchers vital information regarding the mechanisms of cell viability, proliferation, cytotoxicity, and cell death. This information enables researchers to analyze the effects of experimental treatments or conditions on the health of cells. Factors such as the exact research topic, the type of cell being tested, the experimental setting, and the resources that are available all play a role in determining which assay is the most suitable.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kit launches, agreements, partnerships, collaborations & joint ventures, research & development,  and regional expansion of major participants involved in the market.

Cell Viability Assays Market: Growth Factors

Why is demand for cell viability assays expanding across research and industry?

The market for cell viability assays is seeing substantial expansion, which is primarily being driven by the growing demand across a variety of industries, including the pharmaceutical industry, biotechnology, and academic research. This expansion is being driven by a number of factors, one of which is the unrelenting search for innovative treatments, which calls for procedures that are both efficient and reliable for drug development and conducting toxicity testing.

In addition, developments in assay technologies, including automation and high-content imaging, are contributing to the expansion of the market by increasing both the throughput and the accuracy of the measurement. Demand is further fueled by the growing prevalence of chronic diseases, which has led to an increased emphasis on personalized treatment and regenerative therapies, both of which are areas in which cell viability assays play a critical role. Additionally, the increasing investments in biosciences research around the world highlight the market's potential for continuous expansion, which promises sustained growth in the years to come.

Cell Viability Assays Market: Restraints

What factors are limiting broader adoption of cell viability assay technologies?

The high cost of specialized instruments such as automated cell counters, flow cytometers, and imaging systems can restrict access for smaller laboratories and institutions with limited budgets. These capital expenses, combined with ongoing reagent and maintenance costs, may delay or reduce the scale of assay implementation in resource-constrained environments.

Technical complexity associated with certain assay protocols and the need for skilled personnel to ensure accurate interpretation of results also present barriers. Variations in cell types and experimental conditions require careful method selection and optimization, which can slow routine adoption in less specialized settings.

Request Free Sample

Cell Viability Assays Market: Report Scope

Cell Viability Assays Market: Segmentation

The cell viability assays market is segmented by product, application, end-user, and region. All the segments of the cell viability assays market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on Product, the cell viability assays market is divided into consumables and instruments. The consumables segment is anticipated to dominate the market because of the growing demand for assay kits and reagents in cell-related research activities. These products, including tetrazolium reduction kits, resazurin kits, calcein-AM kits, reagents, and microplates, are required for routine experiments and generate recurring revenue. Instruments, encompassing automated cell counters, spectrophotometers, cell imaging and analysis systems, and flow cytometers, form the second major category and support higher-throughput and more sophisticated analysis. The continuous need for consumables in expanding cell-based research drives overall segment growth and underpins market expansion.

Based on Application, the cell viability assays market is divided into basic research, stem cell research, drug discovery and development, clinical and diagnostic applications, and others. The drug discovery and development segment held the largest share owing to the increasing prevalence of infectious and chronic diseases that necessitate efficient screening, toxicity testing, and compound evaluation. Basic research and stem cell research represent important secondary areas that sustain demand through fundamental investigations and regenerative medicine studies. Clinical and diagnostic applications are expanding as viability assessment becomes more integrated into patient-related testing, collectively advancing market development across the application landscape.

Based on End-User, the cell viability assays market is divided into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others. Pharmaceutical and biotechnology companies dominate the market due to the rising number of such organizations and the intensive research activities they conduct in drug discovery and development. Academic and research institutes form a foundational user base that drives method innovation and basic discovery. Hospitals and diagnostic laboratories contribute through clinical applications, while the combined activity of these end users supports sustained demand and market growth.

Cell Viability Assays Market: Regional Analysis

Why will North America continue to dominate the global market during the projection period?

North America is predicted to lead the global cell viability assays market in the upcoming years. The region benefits from a high prevalence of infectious diseases, extensive research activities, and the presence of well-developed research and clinical laboratories. Strong pharmaceutical and biotechnology industries, supported by substantial government and private funding, drive continuous investment in advanced assay technologies and cell-based studies. The United States in particular maintains a dense ecosystem of academic institutions, contract research organizations, and industry laboratories that routinely apply viability assays in drug development and basic research. These factors enable North America to set performance standards, accelerate innovation, and influence global adoption patterns throughout the forecast period.

Asia Pacific is expected to show the highest growth rate, supported by a large patient pool, high prevalence of chronic and infectious diseases, and increasing research activities related to drug and pharmaceutical product development. Europe maintains steady demand through established biomedical research networks and quality-focused laboratory standards. Latin America and the Middle East & Africa represent emerging markets where expanding research infrastructure and rising disease burden are expected to support gradual increases in assay adoption.

Cell Viability Assays Market: Competitive Landscape

Some key players of the global cell viability assays market are

• Bio-Rad Laboratories. Inc.
• GE Healthcare
• PerkinElmer
• Danaher Corporation
• Promega Corporation
• Thermo Fisher Scientific
• BioTek Instruments
• Biotium
• Merck
• Becton
• Dickinson, and Company
• G-Biosciences

Segments Covered

This report segments the global cell viability assays market as follows:

By Product 

• Consumables
  • Assay Kits
    • Tetrazolium Reduction Assay Kits
    • Resazurin Cell Viability Assay Kits
    • Calcein-AM Cell Viability Assay Kits
    • Others
  • Reagents
  • Microplates
• Instruments
  • Automated Cell Counters
  • Spectrophotometers
  • Cell Imaging and Analysis Systems
  • Flow Cytometers

By Application 

• Basic Research
• Stem Cell Research
• Drug Discovery and Development
• Clinical and Diagnostic Applications
• Others

By End-User 

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America